T cell tolerance in transplantation: Possibilities for therapeutic intervention

Expert Opinion on Therapeutic Targets

Volumn 6, Issue 5, 2002, Pages 583-599

  Cobbold, Stephen P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CD4; Gene expression; IL 10; Immune therapy; Microarray; Regulatory T cells; Serial analysis of gene expression (SAGE); TGF ; tr1; Transplantation tolerance

Indexed keywords

ALEMTUZUMAB; B7 ANTIGEN; CD2 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD45 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN; CYTOKINE; CYTOKINE RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; RAPAMYCIN; RECOMBINANT INTERLEUKIN 10; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CELL ACTIVITY; CELL TRANSPLANTATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION; GENETIC ANALYSIS; GRAFT REJECTION; HUMAN; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE FUNCTION; NEPHROTOXICITY; NONHUMAN; REVIEW; RODENT; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; AUTOIMMUNITY; CD40 LIGAND; CYTOKINES; DENDRITIC CELLS; DRUG DESIGN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; RATS; RATS, INBRED STRAINS; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION CHIMERA;

EID: 0036401615     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.6.5.583     Document Type: Review

References (108)

1. BILLINGHAM RE, BRENT L, MEDAWAR PB: Acquired immunological tolerance to foreign cells. Nature (1953) 172:603-606.
2. SPEISER DE PIRCHER H, OHASHI PS, KYBURZ D, HENGARTNER H, ZINKERNAGEL RM: Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogeny. J. Exp. Med. (1992) 175(5):1277-1283.
3. HALE G, WALDMANN H: Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection. Bone Marrow Transplant. (1996) 17(3):305-308.
4. WOOD K, SACHS DH: Chimerism and transplantation tolerance: cause and effect. Immunol. Today (1996) 17(12):584-587.
5. LI Y, LI XC, ZHENG XX, WELLS AD, TURKA LA, STROM TB: Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat. Med. (1999) 5(11):1298-1302.
6. BENJAMIN RJ, WALDMANN H: Induction of tolerance by monoclonal antibody therapy. Nature (1986) 320:499.
7. + regulatory cells? Immunity (2001) 14(4):399-406.
8. QIN S, COBBOLD SP, POPE H et al.: 'Infectious' transplantation tolerance. Science (1993) 259(5097):974-977.
9. MARSHALL SE, COBBOLD SP, DAVIES JD, MARTIN GM, PHILLIPS JM, WALDMANN H: Tolerance and suppression in a primed immune system. Transplantation (1996) 62(11):1614-1621.
10. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. (2001) 193(11):1295-1302.
11. + cells: a naturally occurring population of regulatory T cells. Blood (2001) 98(9):2736-2744.
12. WAKKACH A, COTTREZ F, GROUX H: Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J Immunol. (2001) 167(6):3107-3113.
13. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. (2001) 193(11):1285-1294.
14. + T cells with regulatory properties from human blood. J. Exp. Med. (2001) 193(11):1303-1310.
15. COBBOLD SP, MARTIN G, QIN S, WALDMANN H: Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature (1986) 323:164-166.
16. DAVIES JD, COBBOLD SP, WALDMANN H: Strain variation in susceptibility to monoclonal antibody-induced transplantation tolerance. Transplantation (1997) 63:1570-1573.
17. WISE MP, BEMELMAN F, COBBOLD SP, WALDMANN H: Linked suppression of skin graft rejection can operate through indirect recognition. J. Immunol. (1998) 161(11):5813-5816.
18. THAM EL, SHRIKANT P, MESCHER MF: Activation-induced nonresponsiveness: a Th-dependent regulatory checkpoint in the CTL response. J. Immunol. (2002) 168(3):1190-1197.
19. + cells regulate CD8 cell anergy in neonatal tolerant mice. Transplantation (1999) 68(12):1891-1897.
20. + immunoregulatory cells. J. Immunol. (2001) 167(3):1137-1140.
21. + T cells. Proc. Natl. Acad. Sci. USA (2002) 99(13):8832-8837.
22. + suppressor T cells in vivo. Nat. Immunol. (2002) 3:33-41.
23. DAVIES JD, LEONG LY, MELLOR A, COBBOLD SP, WALDMANN H: T cell suppression in transplantation tolerance through linked recognition. J. Immunol. (1996) 156(10):3602-3607.
24. CHEN ZK, COBBOLD SP, WALDMANN H, METCALFE S: Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation (1996) 62(9):1200-1206.
25. BRETSCHER P, COHN M: A theory of self-nonself discrimination. Science (1970) 169:1042.
26. +) T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin. Invest. (1999) 104(12):1715-1722.
27. GRACA L, HONEY K, ADAMS E, COBBOLD SP, WALDMANN H: Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J. Immunol. (2000) 165(9):4783-4786.
28. WILLIAMS MA, TRAMBLEY J, HA J et al.: Genetic characterization of strain differences in the ability to mediate CD40/ CD28 independent rejection of skin allografts. J Immunol. (2000) 165(12):6849-6857.
29. LU L, LI W, ZHONG C et al.: Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation (1999) 68(6):747-757.
30. STUBER E, STROBER W, NEURATH M: Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. (1996) 183(2):693-698.
31. RULIFSON IC, SPERLING AI, FIELDS PE, FITCH FW, BLUESTONE JA: CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. (1997) 158(2):658-665.
32. + T cells or B cells. J. Immunol. (1998) 161(4):1868-1874.
33. CALNE R, FRIEND P, MOFFATS S et al.: Prope tolerance, perioperative campth 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancer (1998) 351 (9117):1701-1702.
34. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. (2001) 31(4):1247-1254.
35. + T cells J. Exp. Med. (1996) 183(6):2669-2674.
36. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. (2000) 192(2):303-310.
37. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. (2002) 168(12):5979-83.
38. + regulatory cells in acquired MHC tolerance. Immunol. Rev. (2001) 182:99-112.
39. + and CD25- subpopulations. J. Immunol. (2000) 165(6):3105-3110.
40. + regulatory T cells. J. Immunol. (2002) 168(4):1644-1648.
41. + regulatory T cells induced by an agonist self-peptide. Nat. Immun. (2001) 2(4):301-306.
42. + regulatory T cells in anti-myelin basic protein T cells receptor transgenic mice. Proc. Natl. Acad. Sci. USA (2002) 99(12):8213-8218.
43. + regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J. Immunol. (2002) 168(9):4399-4405.
44. + T-cell development is regulated by at least 2 distinct mechanisms. Blood (2002) 99(2):555-560.
45. + T cells. J. Immunol. (2002) 168(2)613-620.
46. + T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. (2001) 31(4):1122-1131.
47. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. (1996) 184(1):241-251.
48. ASSEMAN C, MAUZE S, LEACH MW, COFFMAN RL, POWRIE F: An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. (1999) 190(7):995-1004.
49. + T-cell subset inhibit antigen-specific T cell responses and prevents colitis. Nature (1997) 389(6652):737-742.
50. + T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J. Immunol. (1999) 163:3684-3691.
51. + T cells is induced by immunosuppressive drugs and inhibited by T helper Type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. (2002) 195(5)603-616.
52. LEVINGS MK, SANGREGORIO R, GALBIATI F, SQUADRONE S, DE WAAL MALEFYT R, RONCAROLO MG: IFN-alpha and IL-10 induce the differentiation of human Type 1 T regulatory cells. J. Immunol. (2001) 166(9):5530-9.
53. -) regulatory cells mediate dominant transplantation tolerance. J. Immunol. (2002) 168(11):5558-5565.
54. HARA M, KINGSLEY CI, NIIMI M et al.: IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. (2001) 166(6):3789-3796.
55. ZELENIKA D, ADAMS E, HUMM S et al.: Regulatory T cells overexpress a subset of Th2 gene transcripts. J. Immunol. 2002) 168(3):1069-1079.
56. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. (2001) 166(5):3008-3018.
57. KOSIEWICZ MM, ALARD P, STREILEIN JW: Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment IFN-gamma and induction of TGF-beta and IL-4 production. J. Immunol. (1998) 161(10):5382-5390.
58. WEINER HL: Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol. Rev. (2001) 182:207-214.
59. SHULL MM, ORMSBY I, KIER AB et al.: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature (1992) 359(6397):693-699.
60. + regulatory T cells from human peripheral blood. J. Immunol. (2001) 166(12):7282-7289.
61. + Regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. (2002). 196:237-246.
62. + regulatory, contact-dependent T cells induce interleukin 10 producing, contact independent Type 1-like regulatory T cells. J. Exp. Med. (2002) 196:247-253.
63. + T helper cells. J. Exp. Med. (2002) 196:255-260.
64. +) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. (2001) 194(5):629-644.
65. +) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immun. (2002) 3(2):135-142.
66. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity (2002) 16:311-323.
67. MA A, DATTA M, MARGOSIAN E, CHEN J, HORAK I: T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J. Exp. Med. (1995) 182(5):1567-1572.
68. WILLERFORD DM, CHEN J, FERRY JA, DAVIDSON L, MA A, ALT FW: Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity (1995) 3(4):521-530.
69. TIVOL EA, BORRIELLO F, SCHWEITZER AN, LYNCH WP, BLUESTONE JA, SHARPE AH: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity (1995) 3(5):541-547.
70. + regulatory cells that control intestinal inflammation. J. Exp. Med. (2000) 192(2):295-302.
71. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. (2000) 192(2):303-310.
72. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol. (2002) 168(3):1080-1086.
73. WALDMANN TA, O'SHEA J: The use of antibodies against the IL-2 receptor in transplantation. Curr. Opin. Immunol. (1998) 10(5):507-512.
74. KIRKMAN RL, BARRETT LV, GAULTON GN, KELLEY VE, YTHIER A, STROM TB: Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice. J. Exp. Med. (1985) 162(1)358-362.
75. SCHNEIDER TM, KUPIEC-WEGLINSKI JW, TOWPIK E et al.: Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody. Transplantation (1986) 42(2):191-196.
76. ONIZUKA S, TAWARA I, SHIMIZU J, SAKAGUCHI S, FUJITA T, NAKAYAMA E: Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res. (1999) 59(13):3128-3133.
77. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. (2000) 30(6):1538-1543.
78. + immunoregulatory T cells is antigen nonspecific. J. Immunol. (2000) 164:183-190.
79. +) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. (2000) 192:1213-1222.
80. TONE M, TONE Y, FAIRCHILD PJ, WYKES M, WALDMANN H: Regulation of CD40 function by its isoforms generated through alternative splicing. Proc. Natl. Acad. Sci. USA (2001) 98(4):1751-1756.
81. DHODAPKAR MV, STEINMANN RM, KRASOVSKY J, MUNZ C, BHARDWAJ N: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. (2001) 193:233-238.
82. STEINBRINK K, WOLFL M, JONULEIT H, KNOP J, ENK AH: Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. (1997) 159(10):4772-4780.
83. +) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood (2002) 99:2468-2476.
84. GREGORI S, CASORATI M, AMUCHASTEGUI S, SMIROLDO S, DAVALLI AM, ADORINI L: Regulatory T cells induced by 1 alpha, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. (2001) 167(4):1945-1953.
85. YOSHIMURA S, BONDESON J, BRENNAN FM, FOXWELL BM, FELDMANN M: Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur. J. Immunol. (2001) 31(6):1883-1893.
86. TAKAYAMA T, NISHIOKA Y, LU L, LOTZE MT, TAHARA H, THOMSON AW: Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation (1998) 66(12):1567-1574.
87. FAIRCHILD PJ, BROOK FA, GARDNER RL et al.: Directed differentiation of dendritic cells from mouse embryonic stem cells. Curr. Biol. (2000) 10(23):1515-1518.
88. HOYNE GF, DALLMANN MJ, LAMB JR. T-cell regulation of peripheral tolerance and immunity: the potential role for Notch signalling. Immunology (2000) 100(3):281-288.
89. + T cells. Int. Immunol. (2000) 12(2):177-185.
90. HOYNE GF, DALLMAN MJ, LAMB JR: Linked suppression in peripheral T cell tolerance to the house dust mite derived allergen Der p 1. Int. Arch. Allergy Immunol. (1999) 118(2-4):122-124.
91. GRACA L, COBBOLD SP, WADLMANN H: Identification of regulatory T cells in tolerated allografts. J. Exp. Med. (2002) 195(12):1641-1646.
92. KE B, RITTER T, KATO H et al.: Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients. J. Immunol. (2000) 164(11):5739-5745.
93. CHANDRAKER A, AZUMA H, NADEAU K et al.: Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J. Clin. Invest. (1998) 101(11):2309-2318.
94. KANG SM, HOFFMANN A, LE D, SPRINGER ML, STOCK PG, BLAU HM: Immune response and myoblasts that express Fas ligand. Science (1997) 278(5341):1322-1324.
95. ZHANG HG, SU X, LIU D et al.: Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells. J. Immunol. (1999) 162(3):1423-1430.
96. HONEY K, COBBOLD SP, WALDMANN H: Dominant tolerance and linked suppression induced by therapeutic antibodies do not depend on Fas-FasL interactions. Transplantation (2000) 69(8):1683-1689.
97. LECHNER O, LAUBER J, FRANZKE A, SARUKHAN A, VON BOEHMER H, BUER J: Fingerprints of anergic T cells. Curr. Biol. (2001) 11(8):587-595.
98. CHEN Z, DEHM S, BONHAM K et al.: DNA array and biological characterization of the impact of the maturation status of mouse dendritic cells on their phenotype and antitumor vaccination efficacy. Cell. Immunol. (2001) 214(1):60-71.
99. SAIURA A, MATAKI C, MURAKAMI T et al.: A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation (2001) 72(2):320-329.
100. AKALIN E, HENRIX RC, POLAVARAPU RG et al.: Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology. Transplantation (2001) 72(5):948-953.
101. SAIURA A, KOHRO T, YAMAMOTO T et al.: Detection of an up-regulation of a group of chemokine genes in routine cardiac allograft in the absence of interferon-gamma by means of DNA microarray. Transplantation (2002) 73(9):1480-1486.
102. CHRISTOPHER K, MUELLER TF, MA C, LIANG Y, PERKINS D: Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles. J. Immunol. (2002) 169:522-530.
103. NAGAI S, HASHIMOTO S, YAMASHITA T et al.: Comprehensive gene expression profile of human activated Th1- and Th2-polarized cells. Int. Immunol. (2001) 13(3):367-376.
104. HASHIMOTO SI, SUZUKI T, NAGAI S, YAMASHITA T, TOYODA N, MATSUSHIMA K: Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood (2000) 96(6):2206-2214.
105. HASHIMOTO S, SUZUKI T, DONG HY, NAGAI S, YAMAZAKI N, MATSUSHIMA K: Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood (1999) 94(3):845-852.
106. + T-cell subsets in determining transplantation rejection or tolerance. Immunol. Rev. (2001) 182:164-179.
107. VENKATARAMAN C, SCHAEFER G, SCHINDLER U: Cutting edge: Chandra, a novel four-transmembrane domain protein differentially expressed in helper Type 1 lymphocytes. J. Immunol. (2000) 165(2):632-636.
108. CHANG, CC CIUBOTARIU R, MANAVALAN JS et al.: Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immun. (2002) 3(3):237-243.